It is with great sadness that I share the news of Dr. Alan Garber’s passing yesterday on April 9, 2020. Dr. Garber was a Charter Member of AACE, as well as a Past President of both AACE and ACE.
Over the years, Dr. Garber has been a well-known voice in our Endocrinology community. Since joining AACE in 1992, Dr. Garber had either served as a member or chair of multiple AACE and ACE committees – including writing committees for consensus statements, guidelines, algorithms, editorial boards, resource centers, and task forces. In 2005, he served as Co-Chair of the 14th AACE Annual Scientific & Clinical Congress.
Throughout his career, Dr. Garber authored and co-authored over 350 publications, and held many positions including Professor at Baylor College of Medicine and Chief of Endocrinology at The Methodist Hospital in Texas. He also served as a consultant to several medical associations including the American Heart Association, the American College of Cardiology, the National Kidney Foundation, and the National Heart, Lung, and Blood Institute of the National Institutes of Health, as well as Special Government Employee of the U.S. Food and Drug Administration. When the fundamental trials for metformin were presented to the FDA Advisory Board in 1994, he was one of the five outside experts who did the bulk of the presentation.
Dr. Garber received many Distinguished Service awards from AACE as well as the American Diabetes Association (ADA) and other associations. He was a 2018 recipient of the ACE Master of the American College of Endocrinology (MACE).
While we are all saddened to lose one of the great contributors to our medical specialty, I am forever grateful for Dr. Garber’s dedication to health care and decades of contributions to our profession and the patients we serve.
Please join me in offering sincerest condolences to Dr. Garber’s wife, Susan, and their family, as well as to all whose lives and careers were touched by his generosity and influence.
Sandra L. Weber, MD, FACP, FACE